Tahir Misbah bought MAZE
September 2, 2025 · Form 4 insider transaction
Tahir Misbah bought 325,000 shares of Maze Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Acquired (buy-side)
Shares
325,000
Price
$0.00
Total value
N/A
InsiderTahir Misbah
RoleOfficer
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateSeptember 2, 2025
Filing dateSeptember 2, 2025
Shares owned after325,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The option shall vest as to 1/4th of the total award on September 2, 2026, and thereafter shall vest as to 1/48th of the total award on the monthly anniversary thereof, subject to the reporting person's continued service to the Issuer on each vesting date.